Xphyto Therapeutics, Pharmacielo, and the opaque world of cannabis imports and exports
XPhyto Therapeutics Corp (CSE:XPHY) has seen a significant amount of dollar weighted volume of late, relative to its average, as the company works a narrative […]
Cannazeitgeist
Marijuana Datajam: End of an era at Aurora
A mass bloodletting in the cannabis space appears to have reached its peak yesterday as now former Aurora Cannabis CEO Terry Booth handed in his […]
Lift 2020: VCs still bullish on cannabis, just selective
The all time lows in cannabis sector investor sentiment that seem to have dragged on interminably haven’t yet effected Matthew Nordgren. Following a morning full […]
Dumpster $FIRE: Great expectations, Supreme letdown
The market is catching on to paper factory Supreme Cannabis’ board using the company treasury to bail out their other cannabis startups while the usual suspects are busy running interference.
Everybody’s selling something
These touts can’t be foolish enough to attack @mollytime777 and @thecannalysts… $CANN they?
The FDA-CBD Smackdown
$CURA gets some nasty mail from the government. FH looks at the risk to $CWEB, $IAN, $LHS & $TRUL
Send Lawyers Guns and Money: Canntrust falling apart, short Canopy, long OGI
No bottom in sight for Canntrust (TSX:TRST)(NYSE:CTST), and they deserve it. Fundamental Hype on the Canntrust smoking gun. Short Canopy (TSX:WEED)(NYSE:CGC), long Organigram(TSX.V:OGI)(NASDAQ:OGI), and we’re going to tell you why.
Health Canada might be the least of Canntrust’s problems
We’ve got a dire outlook on $CTST $TRST. Feat. cannabis media all-stars @BettingBruiser & @VanmalaS
Bring-me-down Bruce
The near term prospects for a Linton-less $WEED $CGC don’t look good.
Public Float Part 2: The US Markets get high on a marijuana-like substance Akerna (NASDAQ:KERN)
Two days in, the public listing of $KERN is looking very successful. FH looks into the company’s business, cap table and upside. Featuring @timseymour.